Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
about
Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomotherapy.A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer.A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.Spatial mapping of functional pelvic bone marrow using FLT PET.3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: the Shanghai Cancer Hospital experience.Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicityDosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.Whole pelvic intensity-modulated radiotherapy for gynecological malignancies: A review of the literature.A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer.Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer CenterHelical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.An overview of uterine cancer and its management.Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy.Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plansPhase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic MalignanciesRapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.Margin evaluation of translational and rotational set-up errors in intensity modulated radiotherapy for cervical cancer.Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.Does initial 45Gy of pelvic intensity-modulated radiotherapy reduce late complications in patients with locally advanced cervical cancer? A cohort control study using definitive chemoradiotherapy with high-dose rate brachytherapy.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factorsPlanning and delivery of intensity-modulated radiation therapy.Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer.Correlation between bone marrow dose volumes and acute hematological toxicity in postoperative gynecological cancer patients.Complications of pelvic radiation in patients treated for gynecologic malignancies.Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer.Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate doseTowards ultrasound-guided adaptive radiotherapy for cervical cancer: Evaluation of Elekta's semiautomated uterine segmentation method on 3D ultrasound images.Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible.Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.Haemoglobin monitoring in endometrial cancer patients undergoing radiotherapy.Dosimetric comparisons of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy in whole abdominopelvic radiotherapy for gynecologic malignancy.From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.Repeat CT-scan assessment of lymph node motion in locally advanced cervical cancer patients.Dosimetric comparison study between intensity modulated radiation therapy and three‐dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer.
P2860
Q33387475-51A0E832-FBCE-4198-A82D-6E4C161FFE04Q33427911-61D4C6E6-48E8-4F5C-8E06-9A16AF0BAEE0Q33432469-9F63E834-CE35-4DE2-A469-F3DA607932FDQ34009168-38F3F565-20BE-4790-8C6B-B012166528EDQ34169627-FF2828E5-1FD7-4B94-9C1E-D2500590C0CCQ34328838-A503DD84-323E-4DCC-AC3C-6C84DD2DF387Q34439277-1857DEA5-0E64-4CE1-8FB7-D1C993125C37Q34487033-405E868A-381B-43BD-8C2B-8169C38E3192Q35118693-07BD8C59-89C2-48D1-A1F4-7367D571ABE0Q35572060-BD88417C-AF68-426B-B261-ABE5DE03EB3FQ35591833-94DEF46A-8B51-4EBA-9CBB-721A5A34D9A8Q35868207-3DCEAAE6-FD02-4D87-BAD5-1AEB3D4F7921Q35927962-A8C610C2-69D9-46B5-9B4E-942619F90CDCQ36296947-2AE8591E-495C-4380-95A1-BCAF6D52D82CQ36352068-F931560A-B215-4126-A248-93B3EF0F0FC3Q36355793-8360A295-7F3B-461D-8A50-FAC1E82FB8E2Q36389393-ED22D3A8-C25A-482E-965E-F0BCD64AA90AQ36446268-515DDFD6-8795-4775-910B-0A79C3496111Q36499999-BA02799F-392D-42F8-98B3-8C0E0B23B6EAQ36524526-D3ED635F-781C-46E6-A93E-D58FD0256A62Q36609751-0F076859-F50F-4D52-BE94-F23D878AF196Q36614822-E4B6F679-5B7D-4D83-8095-EBDD5B01174BQ36627147-9564A1AD-4E39-4B85-A03D-30020277CF27Q36951099-9290143B-0C2D-46F1-B8E4-DAE02BF9388BQ37013997-78074335-3AF8-41F5-920A-3996E0D613BDQ37297264-A3207FF8-D1FE-4544-9B53-12F0AFD89C95Q37379087-CE622D84-0729-4956-9504-A14D92196EA7Q37520930-534A34B9-EC69-4D0D-8E7A-FB856A64797FQ37563241-F9C2555B-13BC-4E76-91D8-DFCD90450FD6Q38233303-85B7350F-1F68-4A04-A3D1-6D662033330FQ39614458-59F4EB1A-5553-4DB8-A210-8765C1C01B8AQ41532487-48A92F73-76A4-4D21-868B-4CA2D1BA010BQ41551782-E0213558-8D5A-443F-94E8-3B52C0ED32B6Q41599857-5DB17A9F-D31E-4FB5-9B1B-0EE943185236Q41881535-F14965C4-6E56-4155-81DA-590866971AC7Q48333491-F1A128BC-77FC-4672-B733-CFC515406D2CQ48459271-0AEA3DA7-0F8B-4B5E-9DC0-BAC4D67D2616Q48507945-DAD30858-568A-4A8A-9A5E-A7BE1F2CDD78Q48831597-0150C318-DAE5-4AA2-AE18-1D82006A8FF9Q55259477-055E06BF-35D8-437C-8F91-A7C877FB6466
P2860
Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Impact of intensity-modulated ...... with gynecologic malignancies.
@en
type
label
Impact of intensity-modulated ...... with gynecologic malignancies.
@en
prefLabel
Impact of intensity-modulated ...... with gynecologic malignancies.
@en
P2093
P1476
Impact of intensity-modulated ...... with gynecologic malignancies
@en
P2093
Anthony E Lujan
Arno J Mundt
Clark J Brixey
Jacob Rotmensch
S Diane Yamada
P304
P356
10.1016/S0360-3016(02)03801-4
P407
P50
P577
2002-12-01T00:00:00Z